Developmental Funds

发展基金

• 批准号: 7944506
• 负责人: Andrew S Kraft
• 金额: $ 30.4万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2014-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7944506
• 关键词: American Cancer Society; Area; Award; Cancer Center; Cancer Center Support Grant; Development; Faculty; Funding; Goals; Grant; Immunotherapy; Leadership; Medical; Medicine; Pharmacy facility; Recruitment Activity; Research; Research Project Grants; Scientist; South Carolina; Translational Research; Universities; bench to bedside; college; drug discovery; member

The Hollings Cancer Center (HCC) at the Medical University of South Carolina (MUSC) requests $175,000 in developmental funds, 17.5% of the overall direct Cancer Center Support Grant (CCSG) request, that will be used specifically to: Provide three to five pilot research funding grants to HCC members, a total of $120,000 per year, to promote translational research in high priority areas as articulated by the HCC Senior Leadership ¿ Recruit one new faculty scientist with an emphasis on translational immunotherapy in Years 1-3 ($55,000 each year) and a second recruit, a drug discovery scientist, in Years 4-5 ($55,000 each year)

南卡罗来纳医科大学 (MUSC) 的霍林斯癌症中心 (HCC) 请求 175,000 美元 发展资金，占直接癌症中心支持拨款 (CCSG) 总体直接支持拨款 (CCSG) 请求的 17.5%，这将是 专门用于： 向 HCC 成员提供三到五项试点研究资助，每年总计 120,000 美元， 促进 HCC 高级领导层所阐述的高优先领域的转化研究 ¿招募一名新的科学家，重点研究 1-3 年的转化免疫疗法 （每年 55,000 美元），第 4-5 年招募第二名药物发现科学家（每年 55,000 美元）